Primary care doctors should assess women’s BRCA1 and BRCA2 mutation risks if their ancestry is prone to BRCA mutations.
The BRCA gene has a reputation as a “Jewish cancer gene.”
“If people don’t go into this type of testing with that type of understanding, we don’t know what kind of reaction they’re gonna have.”
The free study will take place in New York, Los Angeles, Philadelphia and Boston.
BRCA gene mutations mainly affect women, and certain variants of the mutation can increase risk of breast and ovarian cancer by nearly 50%.
Knowing these mutations will help doctors create personalized treatments based on a patient’s genetic code.
Public health officials trying to fight breast cancer in Australia find the country’s Jewish population especially challenging.
There is a lot of confusion about hereditary cancer risk and genetic testing among patients and doctors alike.
With Ashkenazi Jews facing a 1 in 40 chance of having a BRCA mutation, should all Jewish women be tested?
Rochelle Shoretz, whose own breast cancer diagnosis at age 28 led her to found the national cancer organization Sharsheret, died Sunday at her home in Teaneck, New Jersey. She was 42. The cause of death was complications from breast cancer.